Announcements Trials
Browse Landscape

Phase

Phase 1 1

Status

Completed 1

Sponsor Class

OTHER 1

Study Type

Interventional 1

Sponsor

Cancer Type

Gynecologic 1

Conditions

Fallopian Tube Neoplasms 2Carcinoma, Ovarian Epithelial 2Vulvar Neoplasms 1Vaginal Neoplasms 1Uterine Cervical Neoplasms 1Squamous Cell Carcinoma of Head and Neck 1Pseudomyxoma Peritonei 1Ovarian Neoplasms 1Neoplasm Metastasis 1Leydig Cell Tumor 1Endometrial Neoplasms 1Carcinoma, Non-Small-Cell Lung 1

Interventions

Oxaliplatin 2Mitomycin 2Leucovorin 2Hyperthermic Intraperitoneal Chemotherapy 2Surveys and Questionnaires 1Standard of Care 1Specimen Handling 1Referral and Consultation 1Radiosurgery 1Psychiatric Rehabilitation 1Pharmacogenomic Testing 1Observation 1Nivolumab 1Methods 1Magnetic Resonance Spectroscopy 1Ipilimumab 1Ifosfamide 1Gemcitabine 1Fluorouracil 1Floxuridine 1Early Intervention, Educational 1Doxorubicin 1Cisplatin 1Carboplatin 1CTLA-4 Antigen 1Behavior Therapy 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Pseudomyxoma Peritonei × Pharmacogenomic Testing × Gynecologic × Clear all
NCT01652794 2015-08-04

Carboplatin, Gemcitabine Hydrochloride, and Stereotactic Body Radiation Therapy in Gynecological Cancer

Case Comprehensive Cancer Center

Phase 1 Completed
12 enrolled
Gynecologic

Carcinoma, Ovarian Epithelial, Uterine Cervical Neoplasms, Fallopian Tube Neoplasms, Leydig Cell Tumor, Pseudomyxoma Peritonei, Vaginal Neoplasms, Vulvar Neoplasms, Endometrial Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon âš¡